Showing results (141-150 of 7,515) with videos related to
Sort By:
Pageof 752
Cancer Treatment Reviews|December 1, 1977
Current dilemmas in the management of non-seminomatous germ cell tumors of the testisC WilliamsBritish Journal of Nursing (Mark Allen Publishing)|September 12, 1996
Irriclens: a sterile wound cleanser in an aerosol canC WilliamsThe Journal of Experimental Medicine|April 21, 1997
Identification of amino acid residues important for ligand binding to FasG C Starling, J Bajorath, J Emswiler, et al.Protein Engineering|August 1, 1997
Mutational analysis of the CD6 ligand binding domainJ E Skonier, D L Bodian, J Emswiler, et al.Journal of Molecular Biology|January 7, 1994
Crystallization and preliminary X-ray analysis of the monoclonal anti-tumor antibody BR96 and its complex with the Lewis Y determinantC Y Chang, P D Jeffrey, J Bajorath, et al.Immunity|December 1, 1994
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsP S Linsley, J L Greene, W Brady, et al.Biochemistry|February 15, 1994
CD62/P-selectin binding sites for myeloid cells and sulfatides are overlappingJ Bajorath, D Hollenbaugh, G King, et al.The Journal of Biological Chemistry|September 15, 1991
Inhibition of proteinase K by methoxysuccinyl-Ala-Ala-Pro-Ala-chloromethyl ketone. An x-ray study at 2.2-A resolutionW M Wolf, J Bajorath, A Müller, et al.The Journal of Experimental Medicine|December 1, 1994
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1R J Peach, J Bajorath, W Brady, et al.The Journal of Biological Chemistry|March 7, 1997
Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BBD T Loo, N J Chalupny, J Bajorath, et al.Pageof 752